Michael B. Mason - Feb 10, 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP & Pres., Lilly Diabetes
Signature
/s/ Jonathan Groff for Michael B. Mason, pursuant to authorization on file
Stock symbol
LLY
Transactions as of
Feb 10, 2023
Transactions value $
$2,768,898
Form type
4
Date filed
2/14/2023, 03:49 PM
Previous filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Award $2.77M +8.02K +25.66% $345.12 39.3K Feb 10, 2023 Direct
holding LLY Common Stock 957 Feb 10, 2023 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Award $0 +3.49K $0.00 3.49K Feb 10, 2023 Common Stock 3.49K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.